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Background: The prevalence of diabetes mellitus (DM) is escalating with an aging population, and the
chances of diabetic older patients admitted to long-term care facilities (LTCFs) are increased because of
DM-related complications. However, undiagnosed DM among LTCF residents is a recognized hidden
problem in this setting and may result in adverse outcomes.
Methods: In May 2011, 10 private LTCFs in northern Taipei participated in this study. Trained research
nurses reviewed the medical records and performed physical examinations and blood sampling for all
participants. Diabetes mellitus was diagnosed, based on the levels of fasting glucose, 2-hour postprandial
plasma glucose, and hemoglobin A1c (HbA1c). Patients were categorized as having DM if they met the
diagnostic cut-offs of the aforementioned criteria.
Results: One hundred and ninety-nine residents (mean age, 79.6  10.5 years; 52.3% males) participated
in this study. They were all moderately/severely disabled (Karnofsky Performance Scale mean score was
50  13). Forty-six (23.1%) residents were diabetic, based on their medical records, or were current users
of antidiabetic agents. The prevalence was 29.6% after testing with a mean HbA1c level of 6.9%  0.9%.
The overall undiagnosed DM rate was 4%, 3.5%, and 4.5%, based on fasting glucose, 2-hour postprandial
plasma glucose, and HbA1c criteria, respectively. Diabetic patients had signiﬁcantly higher serum levels
of prealbumin, compared to nondiabetic patients (220.8 ± 45.9 vs. 201.1 ± 62.2 mg/L; p ¼ 0.03), but there
were no differences in the levels of hemoglobin, serum albumin, or total cholesterol. Diabetic patients
had a signiﬁcantly higher serum triglyceride level, compared to the nondiabetic patients (1.6 ± 0.7 vs. 1.1
± 0.5 mmol/L; p < 0.01) and a lower high-density lipoprotein level (1.0 ± 0.3 vs. 1.2 ± 0.3 mmol/L;
p < 0.01). Among 43 pharmacologically treated diabetic patients, 65.1% (28/43) of patients were using
oral antidiabetic agents and 41.9% (18/43) of patients had been prescribed insulin, whereas 32.6% of the
patients were managed by combination therapy.
Conclusion: The prevalence of DM among LTCF residents in Taipei was 29.6%, and the undiagnosed rate
was no more than 5%, based on fasting glucose, 2-hour postprandial plasma glucose, or HbA1c. Further
study is needed for the optimal treatment strategy of DM in LTCFs.
Copyright  2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.Gerontology, Taipei Veterans
ad, Taipei 11217, Taiwan.
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Diabetes mellitus (DM) is a prevalent disease that may result in
excess morbidity,1 functional impairment or disability,2e4 mortal-
ity, reduced life expectancy,5,6 and increased chance of placementy Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
 
Table 1
Comparison of residents with and without diabetes in long-term care homes.
DM (n ¼ 59) No DM (n ¼ 140) p
Age (y) 78.0  10.5 80.3  10.5 0.153
Sex, male, % (n) 45.8% (27) 55% (77) 0.233
BMI (kg/m2) 22.1  3.5 21.1  4.3 0.137
Systolic blood pressure (mmHg) 124.9  15.8 120.4  14.0 0.051
Functional status (KPS) 49  12 50  14 0.551
HbA1c (mmol/mol) 52.0  10.4 38.0  4.8 <0.001*
(%) 6.9  0.9 5.6  0.4 <0.001*
HOMA-IR 6.4  8.5 1.56  1.2 <0.001*
Serum markers of protein-energy nutrition
Hemoglobin (g/L) 125.0  18.3 120.8  19.6 0.163
Prealbumin (mg/L) 220.8  45.9 201.1  62.2 0.030*
Albumin (g/L) 37.9  3.3 36.8  3.6 0.059
Total cholesterol (mmol/L) 4.4  0.9 4.4  1.0 0.899
Lipid proﬁle
Triglycerides (mmol/L) 1.6  0.7 1.1  0.5 <0.001*
HDL-C (mmol/L) 1.0  0.3 1.2  0.3 <0.001*
LDL-C (mmol/L) 2.9  0.8 2.8  0.8 0.485
Inﬂammatory markers
hs-CRP (nmol/L) 9.8  13.6 12.1  20.0 0.420
WBC count (x109/L) 7.93  2.0 6.79  2.56 0.003*
TNC (x109/L) 5.2  1.7 4.2  2.4 0.007*
TLC (x109/L) 2.0  5.8 1.8  6.7 0.071
Data are presented as mean  SD or % (n).
BMI¼ bodymass index; HbA1c¼ glycosylated hemoglobin A1c; HDL¼ high-density
lipoprotein; HOMA-IR ¼ homeostasis model assessment; hs-CRP ¼ high-sensitivity
C-reactive protein; KPS ¼ Karnofsky Performance Scale; LDL ¼ low-density lipo-
protein; TLC ¼ total lymphocyte count; TNC ¼ total neutrophil count; WBC ¼white
blood cell count.
*p < 0.05.
L.-K. Liu et al. / Journal of Clinical Gerontology & Geriatrics 5 (2014) 68e71 69in a long-term care facility (LTCF) because of disability. In addition
to the higher risk of LTCF admission, diabetic LTCF residents have a
higher risk of developing DM-related complications. The quality of
diabetic care in long-term care settings needs further improvement
because it has been reported that diabetic residents in LTCFs are
less likely than community-dwelling diabetic elders to receive an
annual review, eye examinations, and foot care.7 Undiagnosed DM
in LTCFs residents moreover is reportedly a hidden problem that
may be associated with more hyperosmolar nonketotic coma and
increased mortality in diabetic LTCF residents.8,9
Diabetes mellitus has traditionally been diagnosed by fasting
plasma glucose and 2-hour plasma glucose testing during an oral
glucose tolerance test10,11; however, a glycated hemoglobin A1c
(HbA1c) of 6.5% has been recommended as an alternative method
to diagnose DM12 by the American Diabetes Association (ADA) and
the World Health Organization (WHO).13,14 There are several limi-
tations of using HbA1c to diagnose DM,15 although the superiority
of HbA1c in the diagnosis of DM has been recognized because it
requires no special patient preparation, it has lower biological
variations, and it is unaffected by acute stress or hyperglycemia.16
The aforementioned advantages of HbA1c make it a suitable tool
for diagnosing DM in long-term care settings. Previous reports in
Western countries found a high undiagnosed rate of DM in LTCFs,7
although the rate was only 3.8% in a previous report in Taiwan.17
However, the Taiwanese study tested fasting plasma glucose only,
which may underestimate the prevalence of DM and undiagnosed
DM in the elderly. Therefore, the main purpose of this study was to
evaluate the undiagnosed DM rate by testing the levels of fasting
glucose, postprandial plasma glucose, and HbA1c among LTCF
residents in northern Taiwan.
2. Methods
2.1. Study participants
In May 2011, 10 private LTCFs in northern Taipei with bed ca-
pacities of 20e50 residents were invited to participate in this study.
The residents were enrolled when they, or their families, and the
LTCF managers gave full consent and agreed to participate. The
study was approved by the Institutional Review Board of the Taipei
Veterans General Hospital (Taipei, Taiwan).
2.2. Demography and physical examinations
For each participant, chart records in the LTCFs were reviewed in
detail with a special focus on a DM diagnosis and use of oral anti-
diabetic agents or insulin. Age, sex, functional status (evaluated by
the Karnofsky Performance Scale),18 height, and weight were
recorded. The body mass index (BMI) was calculated accordingly.
2.3. Diabetes mellitus, biochemistry, and insulin resistance
Diabetes mellitus was diagnosed primarily on the basis of the
medical chart records in the LTCFs. In this study, all participants
underwent blood testing after an 8-hour overnight fast, which
included fasting plasma glucose; serum levels of prealbumin, al-
bumin, total cholesterol, triglyceride, high- and low-density lipo-
protein cholesterol, creatinine, insulin, and HbA1c; and complete
blood cell count. For all participants, 2-hour postprandial plasma
glucose was tested. A diagnosis of DM was based on the criteria of
the American Diabetes Association in 2011.13 Patients were cate-
gorized as having DM if they met the criteria of DM by fasting
glucose, postprandial plasma glucose, or HbA1c. Insulin resistance
was measured by homeostasis model assessment (HOMA-IR).192.4. Statistical analysis
Continuous variables of the data in the text and tables were
expressed as mean  standard deviation. Categorical data are
expressed as percentages. Comparisons of categorical variables
were performed by Chi-square test or Fisher’s exact test. Compar-
isons of continuous variables were performed by the Student t test
or ManneWhitney U test when appropriate. The kappa value was
used to determine the consistency of the DM diagnosis based on
fasting glucose, 2-hour postprandial plasma glucose, and HbA1c.
For all tests, a p < 0.05 (i.e., two-tailed) was considered signiﬁcant.3. Results
In this study, 199 residents participated from 10 private LTCFs.
The mean age of all participants was 79.6  10.5 years and 52.3% of
them were males. Among the residents, 4.5% of residents needed
frequent oxygen therapy, 37.2% of residents were fed by nasogastric
tubes, and 27.6% of residents had a long-term indwelling urinary
catheter. All participants were moderately/severely disabled (with
a mean Karnofsky Performance Scale score of 50  13).
Forty-six (23.1%) participants were diabetic, according to the
medical records of the LTCFs, or currently used antidiabetic agents;
43 (93.5%) participants were pharmaceutically treated. The data of
fasting glucose, 2-hour postprandial plasma glucose, and HbA1c of
all participants were compared and showed that 8 patients, 7 pa-
tients, and 9 patients, respectively, had undiagnosed DM. The
overall prevalence of undiagnosed DM in this study was 4% (fasting
glucose), 3.5% (2-hour postprandial plasma glucose), and 4.5%
(HbA1c), based on the aforementioned diagnostic criteria. In total,
7.5% (15/199) of participants had undiagnosed DM on combining all
three diagnostic criteria, and the prevalence of DM in this studywas
29.6%.
Table 1 shows the comparisons of demographic characteristics,
nutritional markers, lipid proﬁle, and inﬂammatory markers
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mographic characteristics and functional status were similar be-
tween the groups, but diabetic patients had signiﬁcantly higher
levels of HbA1c and HOMA-IR. A comparison of protein-energy
nutritional markers showed that diabetic patients, compared to
the nondiabetic patients, had signiﬁcantly higher serum levels of
prealbumin (220.8 ± 45.9 vs. 201.1 ± 62.2 mg/L; p ¼ 0.03), but no
had difference in the levels of hemoglobin, serum albumin, or total
cholesterol. However, diabetic patients had signiﬁcantly higher
levels of serum triglyceride (1.6 ± 0.7 vs. 1.1 ± 0.5 mmol/L; p < 0.01)
and lower high-density lipoprotein level (1.0 ± 0.3 vs. 1.2 ± 0.3
mmol/L; p< 0.01), which were compatible with the presentation of
diabetic dyslipidemia. The serum levels of high-sensitivity C-reac-
tive protein were similar between the groups. The white blood cell
count and total neutrophil count were both higher in diabetic pa-
tients, which implied a chronic inﬂammatory status among diabetic
LTCF residents.
Of the 43 pharmacologically treated diabetic patients, 65.1% (28/
43) of residents were using oral antidiabetic agents and 41.9% (18/
43) of residents had been prescribed insulin. Most residents were
managed by monotherapy; 32.6% (14/43) of the residents were
controlled by combination therapy (Table 2). For all diabetic pa-
tients, the mean HbA1c was controlled at 6.9%  0.9%.4. Discussion
In this study, the overall prevalence of DM among LTCF residents
was 29.6%, after the reevaluation of a DM diagnosis. The prevalence
of DM in United Kingdom care homes ranges between 9.9% and
20.0%,20e22 which is lower than the results of this study. However,
in the United States, 14.5% of nursing home residents were diag-
nosed as having DM in 1977,23 which became 17.2% in 1999,24 and
21%, in another study in 1999.25 However, the prevalence of DM
may reach as high as 36.1% according to a 2007 report.26 Recent
studies in Taiwan report a DM prevalence of 30.8% and 27.9% in LTCF
settings,17,27 which were similar to the ﬁndings of this study. The
variation in the DM prevalence in different studies may be the
result of several reasons such as different age of the study pop-
ulations, quality of care in LTCFs, DM diagnostic criteria, and the
diagnostic tools used (e.g., questionnaire survey, medical record
review, or blood testing).
The undiagnosed rate of DM in this study was 7.5% (15/199) of
patients in this study, which was signiﬁcantly lower than in other
reports. Sinclair et al22 reported that 14.8% of LTCF residents would
be undiagnosed as having DM, based on the oral glucose tolerance
test. Another study showed that the undiagnosed DM ratewas 8.2%,
based on fasting glucose testing and 2-hour postprandial plasma
glucose testing.28 In Taiwan, the LTCF accreditation system em-
phasizes LTCF residents should undergo annual health check-ups.
Therefore, the lower rate of undiagnosed DM, compared to previ-
ous reports fromWestern countries, may be a systematic factor. The
undiagnosed DM rate may represent quality of care to a certain
degree; however, it may be associated with overtreatment in thisTable 2
Description of pharmaceutical management.
Medication n (%)
Secretagogues
Sulfonylureas 14 (32.6)
Meglitinide 5 (11.6)
Metformin 16 (37.2)
Other OADs 9 (20.9)
Insulin 18 (41.9)
OAD ¼ oral antidiabetic agent.setting. Optimal diabetic care in LTCFs is an extremely difﬁcult issue
that needs extensive research studies for an evidence-based prac-
tice guideline. In our study, the undiagnosed DM rates of LTCF
residents, based on fasting glucose, 2-hour postprandial plasma
glucose, and HbA1c, were 4%, 3.5%, and 4.5%, respectively, which
were surprisingly similar. Because of the physiological character-
istics related to aging, the prevalence of DMmay be higher in older
adults, based on postload plasma glucose testing; however, this was
not shown in this study. Using HbA1c for the diagnosis of DM has
many advantages, except the cost. The effect of aging on HbA1c
remains controversial with some studies claiming no age-related
changes in HbA1c,29 and other studies suggesting that HbA1c un-
derestimates the prevalence of DM.30 In particular, the sensitivity of
HbA1c in diagnosing DM may be low in older Asian patients.31 In
DM diagnosis, HbA1c has several advantages, but several concerns
need to be clariﬁed such as the potential interracial differences in
hemoglobin glycation rates,30 the optimal cut-off point for different
ages and ethnicity backgrounds, and the higher cost of mass
screening programs.
In long-term care settings, the recommended glycemic control
target was set at HbA1c of 8% by the American Geriatrics Society.32
Our previous study clearly demonstrated that tight glycemic con-
trol was associated with a higher frequency of hypoglycemia and
with more functional decline in the follow-up period.17 Moreover,
tight glycemic control in this setting did not prevent LTCF residents
from developing pneumonia.27 Results of this study showed that
physicians tending to LTCF residents were somewhat too aggressive
in glycemic control, which may result in a higher risk of hypogly-
cemia for these patients. Determining the optimal target of glyce-
mic control in LTCFs is difﬁcult, and deserves more investigation to
establish an evidence-based practice guideline for DM control in
LTCFs.
There are several limitations in this study. First, the study was
performed by a convenient sample with a relatively small size. This
studymay not sufﬁciently represent the whole population in LTCFs,
although the results of this study were still of great importance
because of the lack of screening DM by HbA1c in LTCFs. Second, the
treatment protocol of DMwas not standardized among the LTCFs in
this study; therefore, the target of glycemic control may vary be-
tween institutes. Third, the data of hypoglycemia and clinical out-
comes of the participants were not collected in this study, which
limited the possibility of exploring the clinical impact of DM control
in this setting.
Despite the aforementioned limitations, the strength of this
study was the comparisons of DM diagnosis by different diagnostic
criteria in LTCFs, which has not been performed in Taiwan or in
other countries. In conclusion, 23.1% of LTCF residents in Taipei
were diabetic when using medical records and 29.6% when testing
fasting glucose, 2-hour postprandial plasma glucose, and HbA1c. By
using either one of the diagnostic criteria, the undiagnosed DM rate
was no more than 5%.Conﬂicts of interest
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